ELPIDA®
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ELPIDA®, covering 2022-01-11 to 2022-01-11. Get the full timeline:
Most recent: Clinical Trial Update: Open Labelled, Randomized Study to Evaluate the Efficacy, Safety and Dose Selection of VM-1500A-LAI Drug in HIV-infected Patients Transferred From Previous Stable Therapy (NNRTI + 2NRTI), Including ELPIDA® [Phase 1, Phase 2]